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Mesoporous Silica Nanoparticles Engineered for Ultrasound-
Induced Uptake by Cancer Cells  
Juan L. Parisa,b, Miguel Manzanoa,b, M. Victoria Cabañasa and María Vallet-Regía,b,* 
A novel smart hierarchical ultrasound-responsive mesoporous silica nanocarrier for cancer therapy is here presented. This 
dynamic nanosystem has been designed to display different surface characteristics during its journey towards tumor cells. 
Initially, the anticancer-loaded nanocarriers are shielded with a polyethylene glycol layer. Upon exposure to high 
frequency ultrasound, the polymer shell detaches from the nanoparticles, exposing a positively-charged surface. That 
favors the internalization in human osteosarcoma cells, where release of topotecan takes place, drastically enhancing the 
cytotoxic effect.  
Introduction 
The use of nanoparticles in medicine, in the so-called 
nanomedicine, has the potential of drastically improving 
cancer diagnostics and therapy.1 In this sense, the selective 
accumulation of nanoparticles in tumor tissues due to the 
Enhanced Permeation and Retention (EPR) effect has been 
used as the main rationale to develop nanoparticle-based drug 
delivery devices as therapeutic agents for cancer treatment,2,3 
some of which have already reached the market.4 Grafting 
polyethylene glycol (PEG) chains on the surface of 
nanoparticles, a process known as PEGylation, has been 
proven as an effective way of increasing the circulation time of 
nanoparticles in the bloodstream, thereby allowing a higher 
dose of the nanocarrier to reach the tumor.5 However, 
nanoparticle uptake by cells is hindered due to PEGylation.5 
Besides the passive accumulation of nanoparticles in tumor 
tissues due to the EPR effect, active targeting strategies have 
been extensively explored to improve the efficacy of 
nanomedicines.2 However, active targeting is often 
accompanied by a series of disadvantages of its own. For 
example, PEGylated nanoparticles exposing targeting agents 
are withdrawn faster from systemic circulation than PEGylated 
nanoparticles without further modification.6 This decrease in 
nanoparticle circulation time can indeed diminish the 
therapeutic efficacy of these nanocarriers. Additionally, the 
presence of targeting agents with a very high affinity for the 
target cells can also induce a paradoxical effect: cancer cells in 
the first line of the tumor tissue will interact with the 
nanoparticles in a very strong manner, retaining those 
particles in the periphery of the tumor and effectively 
preventing their distribution to deeper areas.7 This effect has 
been called the “binding site barrier”.  
Hierarchical targeting strategies have been developed to 
overcome the above limitations of targeted nanomedicines.6 In 
these hierarchical approaches, a targeting moiety is included in 
the formulation in a way that it remains hidden during 
nanoparticles transport along the bloodstream and it is later 
exposed once they reach the target tissue by passive 
accumulation. Cellular uptake of these materials can be 
triggered by a stimulus, either internal (such as pH or redox 
conditions)8 or external (such as light).9 In this context, 
pathological changes in internal conditions, like pH, are not 
very exacerbated.10 Additionally, clinicians do not hold any 
control over the behavior of nanoparticles sensitive to internal 
stimuli. Nanoparticles sensitive to external stimuli can be more 
selective in their response, since they will only be activated by 
the voluntary application of the stimulus. However, the level of 
penetration in the tissue and potential damage to surrounding 
healthy tissues could be limitations for external stimuli. For 
example, light is known to penetrate poorly in solid tissues, 
even though Near Infrared light can be employed to improve 
this parameter.10 
High frequency ultrasound can non-invasively penetrate very 
deep into tissues and is well tolerated by the body.10 When an 
ultrasound (US) wave propagates through living tissues in the 
body, several thermal and mechanical effects occur, including 
pressure variation, acoustic fluid streaming, cavitation and 
local hyperthermia, and these effects can be used for different 
medical applications.11 In these sense, we recently employed 
US to successfully trigger doxorubicin release from 
Mesoporous Silica Nanoparticles (MSNs) in cancer cells.12 
However, the use of ultrasound to trigger hierarchical 
targeting materials remains largely unexplored. The objective 
of the present work is to develop a nanoparticle
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Scheme 1. Schematic representation of nanoparticle uptake by cells promoted by ultrasound-induced detachment of PEG shell from positively-charged MSNs.  
that can undergo ultrasound-promoted uptake by cancer cells, 
by means of an ultrasound-induced temperature increase.  
As a model nanoparticle we have selected MSNs due to their 
facile synthesis and functionalization and their high 
physicochemical stability.13–15 Additionally, the textural 
properties of MSNs, such as their high surface area and pore 
volume, will provide high loading capacity of different drugs. 
Nanoparticle uptake by cells is generally enhanced by 
employing internalization ligands (targeting agents) or 
positively charged moieties on the surface of the 
nanoparticles.6 We chose the exposure of a positively charged 
surface as the mechanism to induce cell internalization by 
using amine functionalized MSNs, due to the simplicity and 
broad applicability of this charge-dependent approach.16 The 
positive charge on the nanoparticle surface will be hidden by 
grafting PEG chains on the nanoparticle surface through a 
thermosensitive linker. These PEG chains will be disengaged 
from the nanoparticles by subjecting the material to an 
ultrasound-induced temperature increase, exposing the 
positive charges of the particles. The concept of the material 
designed in this work is shown in Scheme 1. 
Results and Discussion 
It is well known that nanoparticle surface characteristics have 
a great importance in their interactions with biological 
environments. For example, PEGylation is known to increase 
the circulation time of nanoparticles.5 However, cellular 
uptake in PEGylated nanoparticles is hindered.5 On the other 
hand, nanoparticles with positively charged surfaces are 
generally internalized efficiently by cells (due to an 
electrostatic interaction with negatively-charged phospholipids 
in the cell membrane),6,16 but their circulation time is much 
shorter. Therefore, the design of a nanosystem with different 
surface characteristics in the different delivery stages is here 
approached.  
Mesoporous silica nanoparticles decorated with amino groups, 
MSN-NH2, were used in our experiments. These positive 
nanoparticles were shielded, by decorating them with PEG, 
using 4,4’-azobis(4-cyanovaleric acid) (ABCVA) as linker (MSN-
NH2-T-PEG nanoparticles). ABCVA acts here as a 
thermosensitive linker, although it is commonly used as a 
radical initiator in polymer synthesis because it is cleaved 
when heated,17 forming radical species that can start the 
polymerization.12 In our case, the temperature increase by 
using US would induce the cleavage of the ABCVA linker,18,19 
separating PEG chains from the nanoparticle surface. 
PEGylated nanoparticles that are not thermosensitive (MSN-
NH2-PEG) were used as control and prepared by using succinic 
anhydride as a linker (Scheme 2).  
Scheme 2. Schematic representation of the preparation of MSN-NH2-T-PEG and 
MSN-NH2-PEG. 
 
Samples were characterized before and after PEGylation. The 
Scanning Electron Microscopy (SEM) micrographs show that 
particle morphology (round-shaped) is maintained after PEG 
grafting (Figure 1). Small angle X-Ray Diffraction (XRD) patterns 
show that the ordered porous structure is maintained, 
although the intensity of the diffraction maxima decreases 
after PEG grafting, which is in agreement with previous results 
(Figure S1).12 The Fourier-Transformed Infrared (FTIR) spectra 
of MSN-NH2-PEG and MSN-NH2-T-PEG show the presence of 
amide bonds in the material (ca. 1650 cm-1), confirming the 
successful PEG grafting through amide bond formation to the 
nanoparticles (Figure S1). Thermogravimetric analysis (TGA) 
data indicate a percentage of organic matter due to PEG chains 
in the material of around 5.6 % and 5.2 % for MSN-NH2-T-PEG 
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and MSN-NH2-PEG, respectively (after subtracting the residual 
organic matter percentage present in MSN-NH2 before PEG 
grafting). The amount of amino groups in MSN-NH2 was 
8.35x10-5 moles g-1 (as quantified by Fmoc UV assay). From the 
TGA data and knowing the molecular weight of the grafted 
PEG, the percentage of those amino groups occupied by PEG 
was estimated to be 18.2 % and 19.2 % for MSN-NH2-PEG and 
MSN-NH2-T-PEG, respectively. Z potential is modified from 
positive to negative values after PEGylation: +33.8 mV (MSN-
NH2), -32.1 mV (MSN-NH2-PEG) and -30.2 mV (MSN-NH2-T-
PEG), indicating that the positive charge of the surface is 
hidden after the PEGylation process. Since most of the amino 
groups on the nanoparticle are not involved in the linkage to 
PEG, the drastic changes in the Z potential values must be 
attributed to a physical masking of the nanoparticle surface by 
the PEG chains.  
Figure 1. SEM micrographs of MSN-NH2, MSN-NH2-PEG and MSN-NH2-T-PEG. 
All of the above results confirm the successful masking of the 
nanoparticle surface by the PEGylation process. The system 
capacity to change its surface characteristics in response to 
stimuli was then evaluated step by step. First, we studied the 
PEG detachment after thermal and US treatments, then, the 
US-induced cellular uptake and finally, the cytotoxicity when 
the system was loaded with the anticancer drug topotecan. 
The temperature responsiveness of the linker in our 
nanoparticles was evaluated through PEG chain detachment 
after thermal treatment. The PEG here employed (F-PEG-NH2) 
was labeled with fluorescein to evaluate the fluorescence of 
the supernatant after treatment, which allowed the 
quantification of the PEG detached from our nanoparticles. 
Suspensions of MSN-NH2-T-PEG and MSN-NH2-PEG particles in 
phosphate-buffered saline (PBS, 1 mg mL-1) were treated 70 ºC 
overnight to ensure complete cleavage of the ABCVA linker, 
and the supernatants obtained after centrifugation were 
analyzed by fluorimetry. A control experiment at physiological 
temperature (37 ºC) was performed simultaneously as a 
control. Figure 2 shows that fluorescence intensity was only 
detectable in the aqueous medium after MSN-NH2-T-PEG 
suspension treatment at 70 ºC while no significant 
fluorescence was found in the supernatant of sample at 37 ºC. 
As expected, no fluorescence was observed in the samples 
with no thermosensitive linker (MSN-NH2-PEG) independently 
of the temperature. These results show the thermoresponsive 
capacity of MSN-NH2-T-PEG particles thanks to the presence of 
the selected linker which promotes the PEG detachment. After 
PEG detachment had been observed, the exposure of the 
positively-charged nanoparticle surface was evaluated. Z 
potential measurements after thermal treatment are in 
consonance with the fluorescence experiments, since only 
thermally-treated MSN-NH2-T-PEG particles presented positive 
Z potential values (Figure 2). 
Figure 2. Fluorescence intensity of the supernatant of suspensions of MSN-NH2-
PEG and MSN-NH2-T-PEG (obtained with FITC-labeled PEG) after thermal 
treatment at 70 ºC or control experiments at 37 ºC (left); Z potential 
measurements in water of the materials exposed to those same conditions 
(right). 
Once the ability of this system to dissociate the PEG chains 
from its surface in response to temperature was confirmed, 
these materials were subjected to US as an external stimulus, 
to evaluate if a US-induced temperature increase could trigger 
that same behavior. Figure 3 shows the fluorescence of the 
supernatant of MSN-NH2-T-PEG and MSN-NH2-PEG 
suspensions after US exposure for 20 min. Again, PEG 
fluorescence is only observed in the nanoparticles containing 
the thermosensitive linker, which means that the azo moiety in 
the ABCVA linker between PEG and MSN-NH2 (Scheme 2) was 
cleaved in response to the temperature increase induced by 
US. It is worth mentioning that under the US conditions used, 
the macroscopic temperature of the solution was determined 
to be 48 ± 1 ºC (by a thermocouple placed in the setup during 
the experiments). Even though this temperature was above 
the range of therapeutic hyperthermia (40 -45 ºC),20 it was 
much lower than the bulk temperature needed to induce the 
cleavage (70 ºC). This difference could be ascribed to a more 
intense localized heating in the nanoscale related to the 
occurrence of acoustic cavitation.21 These results show that we 
have successfully developed a proof-of-concept material that 
can detach its PEG coating when exposed to an external 
energy source, such as 1.3 MHz ultrasound. 
  
Figure 3. Fluorescence intensity of the supernatant of suspensions of MSN-NH2-
PEG and MSN-NH2-T-PEG (obtained with FITC-labeled PEG) after US exposure 
(1.3 MHz, 100 W, 20 min) (left); Z potential measurements in water of the 
materials exposed to those same conditions (right). 
The next step was to evaluate if this US treatment would be 
sufficient to provide a positively-charged surface. Thus, Z 
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potential measurements of the nanoparticles after US 
treatment were carried out (Figure 3). Positive values were 
only obtained after the US treatment of MSN-NH2-T-PEG, while 
a negative charge was found in MSN-NH2-PEG, in agreement 
with the absence of PEG detachment.  
The results obtained by fluorimetry and Z potential 
measurements show that the application of an external 
stimulus as US provokes the detachment of the PEG chains 
from MSN-NH2, inducing the exposure of protonated amino 
groups and, therefore, conferring a positively-charged surface 
to the nanoparticles. 
The next step was to study if PEG detachment favors 
nanoparticle uptake. To evaluate that, MSN-NH2-T-PEG and 
MSN-NH2-PEG were exposed to US for 20 min prior to their 
incubation with HOS cells for 2 h. The cells were then washed 
with PBS to remove non-internalized nanoparticles and 
nanoparticle uptake was evaluated by fluorescence 
microscopy and flow cytometry (Figure 4).  
Figure 4. Fluorescence microscopy images (left) and flow cytometry data (right) 
of osteosarcoma cells (HOS) incubated with MSN-NH2-PEG and MSN-NH2-T-PEG 
exposed or not to ultrasound. Blue fluorescence shows stained nuclei with DAPI, 
green fluorescence shows MSN core and red fluorescence (inserts in right 
images) shows PEG chains. ns= no significant differences; *p<0.05. 
 
In this experiment, we employed FITC labeled MSN-NH2 and 
RBITC-labeled PEG chains. The results indicate a higher cellular 
uptake of MSN-NH2-T-PEG nanoparticles that had been 
exposed to ultrasound than in any of the other experimental 
groups, in agreement with the surface charge reversion of the 
nanoparticles after the US-induced temperature increase. 
Moreover, a partial lack of co-localization between red and 
green fluorescence in the ultrasound-exposed MSN-NH2-T-PEG 
sample indicates the detachment of PEG chains from the 
nanoparticles (Insert in Figure 4), in agreement with previous 
in vial experiments above shown. For ultrasound-exposed 
MSN-NH2-PEG under the same conditions, red and green 
fluorescence overlap, indicating that PEG chains are still 
attached to the nanoparticles (Insert in Figure 4). To ensure 
that the nanoparticles are internalized by the cells, flow 
cytometry was performed in cells suspensions in trypan blue 
solution, to remove extracellular fluorescence. Normalized 
fluorescence intensity of the cells determined by flow 
cytometry (Figure 4) shows a significant increase in MSN-NH2-
T-PEG uptake after US exposure, while no significant 
differences were found by ultrasound application for MSN-
NH2-PEG. 
Once the nanoparticles are internalized by the tumor cells 
after US stimulus, they should be able to induce their death. 
The therapeutic potential of our system was therefore 
evaluated with a cytotoxicity study, employing topotecan-
loaded nanoparticles. Topotecan is a water-soluble cytotoxic 
drug (classified as a topoisomerase 1 inhibitor, an analog of 
camptothecin). The use of nanocarriers that can release the 
drug in the intracellular compartment leads to very high 
concentrations of the drug, increasing the efficacy of the 
platform. Therefore, relative levels of cell death obtained with 
different nanocarrier formulations in the same cell line could 
also be an indicator of the degree of internalization of the 
different materials studied. To carry out the cytotoxicity 
experiments, topotecan-loaded nanoparticles were incubated 
with HOS cells following the same protocol as the one 
employed for the uptake experiments (incubation for 2 h in 
complete culture medium after 20 min US pretreatment). Cell 
viability was evaluated at two different time points: 2 or 24 h 
since the removal of non-internalized nanoparticles. The 
results of this cell viability study (Figure 5) show that 
significant cell death is only observable with US-exposed TOP-
MSN-NH2-T-PEG, while under all of the other conditions, the 
cells remained viable. These data are in agreement with the 
nanoparticle uptake experiments, since the nanoparticle    
uptake was much less efficient in absence of thermolinker 
and/or US application. 
Figure 5. Cell viability of HOS cells (evaluated by Alamar Blue test) incubated 
with TOP-MSN-NH2-PEG and TOP-MSN-NH2-T-PEG with or without prior US 
application. *p<0.05; **p<0.001 (compared to control). 
 
All of the results here presented confirm the fabrication of a 
smart hierarchical nanoparticle. Initially, the material presents 
a PEGylated surface, which allows it to circulate in the 
50 µm 50 µm
50 µm 50 µm
M
SN
-N
H 2
-P
EG
M
SN
-N
H 2
-T
-P
EG
No US US
50 µM
50 µM
ns
*
*
**
C
e
ll
 v
ia
b
il
it
y
 %
  
 
 
TOP-MSN-NH2-T-PEG
Control No US US No US US
TOP-MSN-NH2-PEG
Journal Name  ARTICLE 
This journal is © The Royal Society of Chemistry 20xx J .  Na m e.,  2 013, 0 0, 1 -3 | 5  
Please do not adjust margins 
Please do not adjust margins 
bloodstream until it is accumulated in the tumor tissue by the 
EPR effect. Once the tumor is reached, the nanosystem would 
change its surface properties in response to the application of 
an external stimulus, enabling a more effective interaction 
with the cancer cells that would lead to nanoparticle uptake. 
The results obtained in this work highlight a great potential for 
ultrasound-induced nanoparticle uptake. Shielding active 
targeting molecules on the nanoparticle surface and exposing 
them only after the application of external stimuli by 
analogous strategies could also improve the specificity of this 
kind of approaches . 
Conclusions 
We have successfully synthesized a smart hierarchical system 
by developing a PEGylated Mesoporous Silica Nanoparticle 
capable of undergoing detachment of the PEG chains under US 
treatment. The application of an external stimulus such as US 
is also capable of displaying positively-charged surface of the 
nanoparticle.   
The exposure of the positively-charged surface induced by 
ultrasound treatment enhanced the cellular uptake of the 
nanoparticles, while the application of ultrasound in a control 
material did not induce any changes in its uptake. Finally, US-
promoted nanoparticle uptake greatly increased the toxicity of 
topotecan-loaded nanoparticles in human osteosarcoma cells. 
Experimental section 
Materials 
The following compounds were purchased from Sigma-Aldrich 
Inc. (Spain): Ammonium nitrate, cetyltrimethylammonium 
bromide (CTAB), tetraethyl orthosilicate (TEOS), (3-
aminopropyl)triethoxysilane (APTES), 9-
Fluorenylmethoxycarbonyl (Fmoc) chloride, piperidine, 
poly(ethylene glycol) bis(amine) average Mn 3400 Da (NH2-
PEG-NH2), dimethylformamide (DMF), N-hydroxysuccinimide 
(NHS), succinic anhydride, 4,4’-azobis(4-cyanovaleric acid) 
(ABCVA), N,N’-dicyclohexylcarbodiimide (DCC), phosphate-
buffered saline (PBS), rhodamine-B isothyocianate (RBITC), 
fluorescein isothyocianate (FITC) and topotecan hydrochloride 
hydrate (TOP). Dulbecco's Modified Eagle's Medium (DMEM), 
penicillin-streptomycin, non-essential aminoacids, trypsin-
EDTA were purchased from Invitrogen (Fisher Scientific, Spain). 
Fetal bovine serum is from Biowest (Labclinics, Spain). These 
compounds were used without further purification. 
 
Characterization Techniques 
The materials were analyzed by small angle X-ray diffraction 
(XRD) in a Philips X’Pert Multipurpose Diffractometer (MPD) 
equipped with Cu Kα radiation. Fourier transformed infrared 
(FTIR) spectra were obtained in a Nicolet Nexus spectrometer 
(Thermo Fisher Scientific) equipped with a Smart Golden Gate 
attenuated total reflectance (ATR) accessory. 
Thermogravimetry and differential thermal analysis (TGA/DTA) 
were performed in a PerkinElmer Pyris Diamond TG/DTA 
analyzer, with 10 ºC/min heating ramps, from room 
temperature to 600 ºC. 1H NMR experiments were carried out 
in a Bruker AV 250 MHz apparatus. Surface morphology was 
analyzed by scanning electron microscopy (SEM) in a JEOL 
6400 electron microscope. Z potential was measured in 
deionized water by means of a Zetasizer Nano ZS (Malvern 
Instruments) equipped with a 633 nm “red” laser. 
Fluorescence spectrometry was used to determine PEG 
detachment by means of a Biotek Synergy 4 device. 
Fluorescence microscopy was performed with an Evos FL Cell 
Imaging System equipped with three Led Lights Cubes (λEX 
(nm); λEM (nm)): DAPI (357/44; 447/60), GFP (470/22; 525/50), 
RFP (531/40; 593/40) from AMG (Advance Microscopy Group). 
Quantitative analysis of cellular uptake was performed by flow 
cytometry (FACS) in a BD FACSCalibur™ cytometer, and results 
were processed using Flowing Software. Ultrasound 
experiments were performed in a commercial laboratory 
ultrasound apparatus (RBI, France), working at 1.3 MHz and 
100 W for 20 min, following similar conditions as those 
described in our previous work.12 
 
Synthesis of PEGylated Mesoporous Silica Nanoparticles 
Amino-functionalized mesoporous silica nanoparticles (MSN-
NH2) were obtained by a modified Stöber method from a 
mixture of TEOS and APTES (90:10 molar ratio) in the presence 
of CTAB as structure-directing agent under basic and very 
dilute conditions, as described elsewhere.16 MSN-NH2 labeled 
with FITC were also obtained by reacting 1 mg of FITC with 2.2 
μL APTES in 100 μL ethanol for 2 h. Then, the reaction mixture 
was added with the TEOS and APTES solution as already 
described.  
The quantification of amino groups available on MSN-NH2 was 
performed by a Fmoc UV assay,22 based on the reaction of 
Fmoc chloride with the amino groups to be quantified. Briefly, 
50 mg of MSN-NH2 were mixed with 125 mg of Fmoc chloride 
(excess), purged with nitrogen and dissolved in 3 mL of dry 
DMF under inert atmosphere. That solution was magnetically 
stirred overnight at room temperature. Then, the material was 
collected by centrifugation and washed with DMF, water (3 
times) and ethanol (twice) to get rid of unbounded Fmoc. That 
material was dried under vacuum. Different portions were 
weighted and dispersed in 1 mL of a solution of 20 % 
piperidine in DMF to deprotect the amino groups and release 
the Fmoc from the material. That reaction was performed 
under sonication for 20 min. After centrifugation, the 
absorbance of the supernatant at 301.5 nm was measured, 
and the amount of Fmoc released from the amines was 
measured. Once the amount of Fmoc released was known, the 
amount of amino groups per mg of material was extrapolated 
(molar ratio 1:1). 
Before the PEGylation process, commercial NH2-PEG-NH2 was 
labeled with FITC (F-PEG-NH2) or RBITC (R-PEG-NH2) in order to 
be detected by green and red fluorescence, respectively. F-
PEG-NH2 was obtained by reacting 100 mg of NH2-PEG-NH2 
with 11 mg of FITC (1:1 molar ratio) in 5 mL of dry DMF under 
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inert atmosphere (N2). The reaction was carried out at room 
temperature under magnetic stirring overnight (under inert 
atmosphere). Then, the reaction products were precipitated in 
diethyl ether and dried at room temperature. The products 
were dissolved in water and F-PEG-NH2 was purified by size 
exclusion chromatography (Sephadex® G-25). 1H NMR spectra 
of different fractions after liophylization were performed to 
select the desired product. R-PEG-NH2 was obtained in a 
similar way, but using 16 mg of RBITC instead of FITC (to 
maintain the 1:1 molar ratio). 
MSN-NH2 functionalization with PEG was carried out through 
DCC/NHS chemistry using a thermosensitive linker such as 
ABCVA to obtain thermosensitive PEGylated nanoparticles 
(MSN-NH2-T-PEG). Similar protocol was followed with succinic 
anhydride as a linker to prepare non-thermosensitive 
PEGylated nanoparticles (MSN-NH2-PEG) to be used as control. 
To obtain MSN-NH2-T-PEG, 1.6 mg of ABCVA were activated 
with 3.4 mg of DCC and 1.9 mg of NHS in 2 mL of dry DMF 
under inert atmosphere with magnetic stirring at room 
temperature for 30 min. Then, 20 mg of F-PEG-NH2 (or R-PEG-
NH2) dissolved in 1 mL of dry DMF were added and stirred for 
2 h at room temperature (molar ratio of 1:1 with ABCVA). 
Finally, 20 mg of MSN-NH2 nanoparticles dispersed in 1 mL of 
dry DMF were added. The reaction medium was stirred 
overnight and the product was collected by centrifugation and 
washed with DMF twice and with water 3 times. The material 
was then dried under vacuum. 
To obtain MSN-NH2-PEG, 20 mg of F-PEG-NH2 (or R-PEG-NH2) 
and 0.6 mg of succinic anhydride were dissolved in 2 mL of dry 
DMF under inert atmosphere, and the mixture was 
magnetically stirred at room temperature for 1.5 h. Then, 1.8 
mg DCC and 1 mg of NHS dissolved in 1 mL of dry DMF were 
added and stirred for other 2 h. Then, 20 mg of MSN-NH2 
nanoparticles dispersed in 1 mL of dry DMF were added and 
reacted overnight. The material was purified as described 
above for MSN-NH2-T-PEG.  
 
Evaluation of stimuli-responsive PEG detachment from the 
material 
To evaluate the detachment of PEG chains from MSN-NH2-PEG 
or MSN-NH2-T-PEG, nanoparticles with FITC-labeled PEG chains 
were employed. Several 1 mL aliquots of suspensions of those 
materials in PBS (1 mg mL-1) were placed in an oven and 
subjected to two different thermal treatments: 37 ºC or 70 ºC 
overnight (samples were sealed to prevent any solvent 
evaporation). Additionally, suspensions of both nanoparticle 
types were exposed to US by using a commercial laboratory 
ultrasound apparatus working at 1.3 MHz and 100 W for 20 
min. A thermocouple was introduced in the experimental 
setup during the ultrasound application experiments to 
evaluate the temperature rise induced by the stimulus. 
After the different treatments, the suspensions were 
centrifuged (10000 rpm, 10 min). The supernatants were 
analyzed by fluorimetry to determine the presence of F-PEG-
NH2 detached from the materials. The materials were washed 
3 times with PBS, dried and stored until further analysis. Z 
potential from those materials was performed in aqueous 
suspension to evaluate any changes on the surface charge of 
the materials after the different treatments. 
 
In vitro nanoparticle uptake and cancer cell killing 
Human Osteosarcoma (HOS) cells were seeded in 24 well 
plates at a density of around 20,000 cells cm-2 24 h before the 
experiments were carried out. Cells were grown in DMEM 
supplemented with 2mM of glutamine, 1 % 
penicillin/streptomycin and 10 % fetal bovine serum, at 37 ºC, 
5 % CO2 and 95 % humidity. 
Nanoparticle uptake by HOS cells was evaluated by 
fluorescence microscopy employing nanoparticles prepared 
with RBITC-labeled PEG and FITC-labeled MSN-NH2. Thus, the 
location of both MSN-NH2 and PEG could be traced with the 
microscope. HOS cells were exposed to a suspension of MSN-
NH2-T-PEG or MSN-NH2-PEG (without or with 20 min US 
pretreatment in both cases) in DMEM culture medium (200 µg 
mL-1) for 2 h. Then, the cells were washed with PBS twice and 
then fixed with a solution of DAPI in methanol. That medium 
was changed with PBS to perform fluorescence microscopy.  
Quantitative analysis of cellular uptake was performed by flow 
cytometry. HOS cells were incubated with the nanoparticles in 
complete culture medium (200 µg mL-1) for 2 h, and after 
washing out non-internalized nanoparticles with PBS, the cells 
were trypsinised, collected by centrifugation and redispersed 
in PBS solution with trypan blue (0.5 %) to remove 
extracellular fluorescence. The fluorescence intensity of 
10,000 cells was quantified by flow cytometry. Statistical 
analysis for differences between groups was carried out by the 
Student’s t test. 
Nanoparticles were loaded with topotecan, an anticancer 
drug, to carry out cytotoxicity experiments. Drug loading was 
performed by dispersing MSN-NH2-PEG, or MSN-NH2-T-PEG, in 
a solution of topotecan (2 mg mL-1 in PBS), and magnetically 
stirring them overnight at room temperature. Those 
nanoparticles containing topotecan, TOP-MSN-NH2-PEG and 
TOP-MSN-NH2-T-PEG, were collected by centrifugation and 
washed with PBS 3 times. Incubation of HOS cells with these 
nanoparticles (without or with 20 min US pretreatment) was 
performed in complete culture media as described above for 
the internalization experiments (2 h of incubation time). After 
washing out non-internalized nanoparticles with PBS, cell 
viability was evaluated at different time points (2 and 24 h) by 
a commercial Alamar Blue test (Invitrogen, Spain), following 
the manufacturer’s instructions. Statistical analysis was carried 
out using the Student´s t test. 
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